Ari Bousbib joined the board of JOGO Health in 2019. He is currently the chairman and chief executive officer of IQVIA. Ari has been serving on the board of directors of The Home Depot since 2007, and is a member of the Harvard Medical School Health Care Policy Advisory Council. In 2008, Ari was appointed by the President of the United States to serve on the President’s Commission on White House Fellowships.

​

Prior to IQVIA, Ari spent 14 years at United Technologies Corporation (UTC), the parent company of Otis Elevator Company, Carrier Corporation, UTC Power, UTC Fire & Security, Pratt & Whitney, Sikorsky Aircraft, and Hamilton Sundstrand, where he held several senior leadership positions. He joined UTC in 1997 as chief strategy and development officer, became chief operating officer of Otis in 2000 and president and chief executive officer of Otis in 2002. In 2008, Ari was appointed president of UTC Commercial Companies with executive leadership responsibility for the worldwide operations of Otis, Carrier, UTC Fire and Security and UTC Power, generating $36 billion in annual revenues and leading a team of 150,000 employees around the world.

​

Ari is a former partner at global management and technology consulting firm Booz Allen Hamilton. He joined the firm in 1987 as an associate and was elected to its partnership in 1992.

​

Sanjai has dedicated the last ten years of his life to working with leading clinical researchers, game designers, data scientists, and rehab professionals from various research institutes across the world to create JOGO — the first-ever digital therapeutics product that used the science of EMG biofeedback to treat neuromuscular diseases.  Sanjai has over 20 years of experience in developing and marketing technology solutions and has a US patent.

Siva has over 23 years of clinical, safety, and postmarketing experience in the pharmaceutical industry. His previous venture, Semantelli, an AI-based drug safety detection and healthcare social media analytics platform was acquired by IQVIA, the world's leading clinical research organization with over 58,000 employees and $11 billion in revenue, where he served as a General Manager for six years.  Siva has two US patents.